Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers around the world. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. It is the supplier of life-sustaining hemodialysis concentrates products to dialysis clinics. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.
企業コードRMTI
会社名Rockwell Medical Inc
上場日Jan 27, 1998
最高経営責任者「CEO」Dr. Mark Strobeck, Ph.D.
従業員数244
証券種類Ordinary Share
決算期末Jan 27
本社所在地30142 Wixom Road
都市WIXOM
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号48393
電話番号18004493353
ウェブサイトhttps://www.rockwellmed.com/
企業コードRMTI
上場日Jan 27, 1998
最高経営責任者「CEO」Dr. Mark Strobeck, Ph.D.
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし